Characterisation of ACE2-like Enzyme from Bacillus cereus sp. as an Alternative Treatment for COVID-19 Patients

Characterisation of ACE2-like Enzyme from Bacillus cereus sp. as an Alternative Treatment for COVID-19 Patients

SARS-CoV-2 infection can lead to downregulation of ACE2, raising pro-inflammatory Angiotensin II levels. Recombinant human ACE2 protein therapy can restore homeostasis but is costly. An alternative is an ACE2-like enzyme with similar effects. The previous research identified a carboxypeptidase prot...

Full description

Saved in:
Bibliographic Details
Main Authors: Alya Sendra Maulida, Novi Arie Anggraeni, Azzania Fibriani
Format: Article
Language:English
Published: Bogor Agricultural University 2024-11-01
Series:Hayati Journal of Biosciences
Online Access:https://journal.ipb.ac.id/index.php/hayati/article/view/57558
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items